Abstract

AYURVEDIC MANAGEMENT OF SICKLE CELL ANEMIA: A COMPREHENSIVE REVIEW

Dr. Minakshi Nargave*, Dr. Sudipt Kumar Rath

Abstract

Sickle Cell Anemia (SCA) is a chronic inherited hemoglobinopathy characterized by the presence of abnormal hemoglobin S (HbS), resulting from a mutation in the β-globin gene. Under hypoxic conditions, the abnormal hemoglobin undergoes polymerization leading to deformation and sickling of red blood cells, chronic hemolysis, vascular occlusion, ischemic tissue injury, recurrent painful crises, progressive organ damage and severe impairment in quality of life. SCA constitutes a major public health burden, particularly among tribal and socioeconomically vulnerable populations in India and other tropical countries. Despite significant advancements in modern medicine, the current therapeutic approach remains largely symptomatic and supportive, including blood transfusion, hydroxyurea therapy, analgesics and bone marrow transplantation. However, these modalities are often associated with limitations such as high cost, adverse effects, lifelong dependency, limited accessibility, and inability to provide complete disease remission in the majority of patients. Ayurveda, the traditional system of Indian medicine, offers a comprehensive and holistic perspective in the management of chronic hematological disorders through its multidimensional therapeutic principles. Although Sickle Cell Anemia is not directly described in classical Ayurvedic literature, the clinical manifestations and pathophysiological features of the disease can be correlated with conditions such as Pandu, Raktadushti, Raktapitta, Dhatukshaya, Ojakshaya and Vata-Pitta predominant disorders. The concept of Beeja Dushti and Beejabhaga Avayava Dushti described in Ayurveda may also provide a theoretical basis for understanding hereditary and genetic disorders. Ayurvedic management emphasizes correction of Agnimandya, elimination of Ama, purification and nourishment of Rakta Dhatu, restoration of tissue integrity, enhancement of Bala and Ojas and prevention of recurrent complications through Rasayana therapy. The present review aims to critically analyze and compile available classical and contemporary literature regarding the Ayurvedic understanding and management of Sickle Cell Anemia. Data were collected from classical Ayurvedic texts including Charaka Samhita, Sushruta Samhita and Ashtanga Hridaya, along with peer-reviewed research articles, clinical studies and online scientific databases such as PubMed, Google Scholar, Scopus, and AYUSH Research Portal. Various Ayurvedic interventions including Rasayana drugs, Raktaprasadana formulations, Balya therapies, Panchakarma procedures, Pathya-Apathya regimens and lifestyle modifications were reviewed and analyzed in the context of their pharmacological and therapeutic relevance in SCA. The review findings indicate that Ayurvedic therapies possess significant potential in improving hematological parameters, reducing oxidative stress and inflammation, minimizing the frequency and severity of vaso-occlusive crises, enhancing immunity, improving digestion and metabolism and promoting overall physical and psychological well-being. Herbal formulations containing Guduchi, Ashwagandha, Amalaki, Punarnava and iron-containing preparations such as Punarnavadi Mandura and Navayasa Lauha demonstrate promising hematinic, antioxidant, immunomodulatory, anti-inflammatory and rejuvenative properties. Panchakarma modalities, particularly mild Vata-Pitta shamana therapies and Basti Karma, may further aid in symptomatic relief and systemic balance. In addition, Ayurvedic dietary guidelines and Rasayana-based preventive strategies may contribute to long-term disease management and improvement in quality of life. In conclusion, Ayurveda offers a holistic, patient-centered, and integrative approach for the supportive management of Sickle Cell Anemia by addressing both the systemic manifestations and the underlying functional imbalance of the body. Although Ayurvedic interventions may not reverse the underlying genetic mutation, they may significantly reduce disease burden, enhance functional capacity, and improve quality of life when used as complementary therapy. Nevertheless, there remains a substantial need for rigorous scientific validation through large-scale randomized controlled trials, molecular studies, and evidence-based interdisciplinary research to establish the efficacy, safety and mechanism of Ayurvedic interventions in Sickle Cell Anemia.

Keywords: Sickle Cell Anemia, Ayurveda, Pandu, Raktadushti, Rasayana, Hemolytic Anemia.